MOSCOW – Russia announced that a batch of its Sputnik V Covid-19 vaccine was produced for the first time in Vietnam, which is battling a new wave of coronavirus infections.
Russian Direct Investment Fund (RDIF), which financially backed Sputnik V, in a statement today said the test batch was produced in partnership with Vietnam’s state-owned pharmaceutical company Vabiotech.
The first samples from the batch will be shipped to the vaccine developer – the Gamaleya Centre here – for quality control, it added.
“RDIF and Vabiotech are actively cooperating in the technology transfer process to provide easier access to Sputnik V for the population of Vietnam,” said the fund’s CEO, Kirill Dmitriyev, in a statement.
Vabiotech president Dat Tuan Do welcomed the announcement saying it “will help provide quality and affordable” vaccines to Vietnam and other countries in the region.
Vietnam has recently faced a surge in new infections with the government putting about a third of the country’s 100 million people under stay-at-home orders to contain the outbreak.
The Southeast Asian nation has been slow to procure and administer vaccines, with just 4.3 million doses given as of Monday.
Russia registered Sputnik V last August, ahead of large-scale clinical trials, prompting concern among experts over the fast-tracked process.
It has since been declared safe and over 90% effective in a report published by leading medical journal The Lancet, restoring confidence in Russia’s shot.
RDIF has signed production agreements with several countries, including India, which is expected to produce several hundred million doses per year.
It said its two-dose vaccine has been approved in 68 countries, adding that it has applied for registration in the European Union. – AFP, July 21, 2021
